Status:
TERMINATED
Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
Oulu University Hospital
Satakunta Central Hospital
Conditions:
Hypertension Secondary to Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is designed to investigate the efficacy of renal nerve denervation in treating drug-resistant hypertension in patients with end stage renal disease.
Detailed Description
Drug resistant hypertension is very common in end stage renal disease treated by dialysis. The prevalence of hypertension has been evaluated to be over 50% and up 80%. In this patient group mortality ...
Eligibility Criteria
Inclusion
- patients with end stage renal disease and drug-resistant blood pressure.
Exclusion
- pregnancy
- secondary hypertension
- unstable coronary artery disease
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01881035
Start Date
May 1 2013
End Date
December 31 2016
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vaasa Central Hospital
Vaasa, Finland, 65130